18
Participants
Start Date
June 1, 2018
Primary Completion Date
November 13, 2019
Study Completion Date
November 13, 2019
Mavoglurant (AFQ056)
2-100mg tablets of Mavoglurant will be administered on the morning of 1 of the 2 experimental days by an RN or the physician investigator.
Placebo
Two matching tablets of placebo will be administered on the morning of 1 of the 2 experimental days by an RN or the physician investigator.
Hartford Hospital, Hartford
Yale University
OTHER